CA2216809A1 - Imidazo[1,2-a]pyridine derivatives - Google Patents
Imidazo[1,2-a]pyridine derivatives Download PDFInfo
- Publication number
- CA2216809A1 CA2216809A1 CA002216809A CA2216809A CA2216809A1 CA 2216809 A1 CA2216809 A1 CA 2216809A1 CA 002216809 A CA002216809 A CA 002216809A CA 2216809 A CA2216809 A CA 2216809A CA 2216809 A1 CA2216809 A1 CA 2216809A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- compounds
- compound
- 4alkyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9506965.4A GB9506965D0 (en) | 1995-04-04 | 1995-04-04 | Chemical compounds |
GB9506965.4 | 1995-04-04 | ||
GBGB9512099.4A GB9512099D0 (en) | 1995-06-14 | 1995-06-14 | Chemical compounds |
GB9512099.4 | 1995-06-14 | ||
GBGB9516117.0A GB9516117D0 (en) | 1995-08-05 | 1995-08-05 | Chemical compounds |
GB9516117.0 | 1995-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2216809A1 true CA2216809A1 (en) | 1996-10-10 |
Family
ID=27267657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002216809A Abandoned CA2216809A1 (en) | 1995-04-04 | 1996-04-02 | Imidazo[1,2-a]pyridine derivatives |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0819127A1 (ja) |
JP (1) | JPH11501049A (ja) |
KR (1) | KR19980703559A (ja) |
CN (1) | CN1186492A (ja) |
AU (1) | AU5276696A (ja) |
BG (1) | BG101934A (ja) |
CA (1) | CA2216809A1 (ja) |
CZ (1) | CZ313397A3 (ja) |
EA (1) | EA199700209A1 (ja) |
HU (1) | HUP9801602A3 (ja) |
IS (1) | IS4570A (ja) |
NO (1) | NO974595L (ja) |
NZ (1) | NZ304886A (ja) |
PL (1) | PL322623A1 (ja) |
SK (1) | SK133297A3 (ja) |
TR (1) | TR199701105T1 (ja) |
WO (1) | WO1996031509A1 (ja) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2764292B1 (fr) * | 1997-06-10 | 2000-12-29 | Innothera Lab Sa | Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique |
US6525053B1 (en) | 1997-08-22 | 2003-02-25 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
US6307047B1 (en) | 1997-08-22 | 2001-10-23 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
DE69816651T2 (de) | 1997-09-05 | 2004-04-01 | Glaxo Group Ltd., Greenford | 2,3-diaryl-pyrazolo[1,5-b]pyridazin derivate, deren herstellung und deren verwendung als cyclooxygenase 2 (cox-2) inhibitoren |
FR2770131A1 (fr) * | 1997-10-27 | 1999-04-30 | Union Pharma Scient Appl | Nouvelle association pharmaceutique a activite analgesique |
FR2771005B1 (fr) * | 1997-11-18 | 2002-06-07 | Union Pharma Scient Appl | Nouvelle association pharmaceutique a activite analgesique |
GB9810920D0 (en) * | 1998-05-21 | 1998-07-22 | Merck Sharp & Dohme | Therapeutic use |
ES2140354B1 (es) * | 1998-08-03 | 2000-11-01 | S A L V A T Lab Sa | Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2. |
TW587079B (en) * | 1998-09-25 | 2004-05-11 | Almirall Prodesfarma Ag | 2-phenylpyran-4-one derivatives |
PL348208A1 (en) * | 1998-11-03 | 2002-05-06 | Glaxo Group Ltd | Pyrazolopyridine derivatives as selective cox-2 inhibitors |
AU2661400A (en) | 1999-02-27 | 2000-09-21 | Glaxo Group Limited | Pyrazolopyridines |
GB9930358D0 (en) | 1999-12-22 | 2000-02-09 | Glaxo Group Ltd | Process for the preparation of chemical compounds |
EP1246621A4 (en) | 1999-12-23 | 2004-11-24 | Nitromed Inc | NITROSED AND NITROSYLATED CYCLOOXYGENASE-2 INHIBITORS, COMPOSITIONS AND METHODS FOR THEIR USE |
GB0002312D0 (en) * | 2000-02-01 | 2000-03-22 | Glaxo Group Ltd | Medicaments |
PE20011333A1 (es) | 2000-03-16 | 2002-01-16 | Almirall Prodesfarma Ag | Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2 |
PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
PT1303265E (pt) | 2000-07-20 | 2007-10-09 | Lauras As | ''utilização de inibidores da cox-2 como imuno-estimulantes, no tratamento do vih ou da sida'' |
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
GB0025449D0 (en) * | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
WO2002048148A2 (en) | 2000-12-15 | 2002-06-20 | Glaxo Group Limited | Pyrazolopyridine derivatives |
JP2004518651A (ja) | 2000-12-15 | 2004-06-24 | グラクソ グループ リミテッド | 治療用化合物 |
ES2227451T3 (es) | 2001-03-08 | 2005-04-01 | Smithkline Beecham Corporation | Derivados de pirazolopiridina. |
WO2002078700A1 (en) | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Pyralopyridines, process for their preparation and use as therapteutic compounds |
US7695736B2 (en) | 2001-04-03 | 2010-04-13 | Pfizer Inc. | Reconstitutable parenteral composition |
JP4219171B2 (ja) | 2001-04-10 | 2009-02-04 | スミスクライン ビーチャム コーポレーション | 抗ウイルス性ピラゾロピリジン化合物 |
ES2242028T3 (es) | 2001-04-27 | 2005-11-01 | Smithkline Beecham Corporation | Derivados de pirazolo(1,5-a)piridina. |
US6756498B2 (en) | 2001-04-27 | 2004-06-29 | Smithkline Beecham Corporation | Process for the preparation of chemical compounds |
IL158667A0 (en) | 2001-06-21 | 2004-05-12 | Smithkline Beecham Corp | Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
DE60211539T2 (de) | 2001-10-05 | 2006-09-21 | Smithkline Beecham Corp. | Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion |
GB0124941D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124936D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124939D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124934D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124938D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124933D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124931D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
ATE373000T1 (de) | 2001-12-11 | 2007-09-15 | Smithkline Beecham Corp | Pyrazolopyridin-derivate als antiherpesmittel |
BRPI0307351B8 (pt) | 2002-02-12 | 2021-05-25 | Smithkline Beecham Corp | composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto |
WO2004002420A2 (en) | 2002-06-28 | 2004-01-08 | Nitromed, Inc. | Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
GB0217757D0 (en) | 2002-07-31 | 2002-09-11 | Glaxo Group Ltd | Novel compounds |
WO2004033454A1 (en) | 2002-10-03 | 2004-04-22 | Smithkline Beecham Corporation | Therapeutic compounds based on pyrazolopyridine derivatives |
KR20040072004A (ko) | 2003-02-07 | 2004-08-16 | 삼성에스디아이 주식회사 | 유기 전계 발광 소자용 발광 화합물 및 그를 이용한 유기전계발광 소자 |
GB0308201D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
GB0308185D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
GB0308186D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
AU2004237439B2 (en) | 2003-05-07 | 2009-09-10 | Osteologix A/S | Treating cartilage/bone conditions with water-soluble strontium salts |
GB0318814D0 (en) | 2003-08-11 | 2003-09-10 | Smithkline Beecham Corp | Novel compounds |
US8067464B2 (en) | 2004-10-04 | 2011-11-29 | Nitromed, Inc. | Compositions and methods using apocynin compounds and nitric oxide donors |
WO2007016677A2 (en) | 2005-08-02 | 2007-02-08 | Nitromed, Inc. | Nitric oxide enhancing antimicrobial compounds, compositions and methods of use |
CA2647859C (en) | 2006-03-29 | 2016-01-05 | Nitromed, Inc. | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
AU2007316417B2 (en) | 2006-11-06 | 2013-08-22 | Tolero Pharmaceuticals, Inc. | Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |
ES2671748T3 (es) | 2011-07-21 | 2018-06-08 | Tolero Pharmaceuticals, Inc. | Inhibidores heterocíclicos de proteína quinasas |
WO2016177776A1 (en) | 2015-05-04 | 2016-11-10 | Academisch Medisch Centrum | Biomarkers for the detection of aspirin insensitivity |
KR20210146290A (ko) | 2019-02-12 | 2021-12-03 | 스미토모 다이니폰 파마 온콜로지, 인크. | 헤테로시클릭 단백질 키나제 억제제를 포함하는 제제 |
WO2022195579A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3455924A (en) * | 1967-02-08 | 1969-07-15 | Upjohn Co | Dianisylimidazoles |
-
1996
- 1996-04-02 JP JP8529971A patent/JPH11501049A/ja active Pending
- 1996-04-02 EP EP96909164A patent/EP0819127A1/en not_active Withdrawn
- 1996-04-02 AU AU52766/96A patent/AU5276696A/en not_active Abandoned
- 1996-04-02 KR KR1019970706963A patent/KR19980703559A/ko not_active Application Discontinuation
- 1996-04-02 PL PL96322623A patent/PL322623A1/xx unknown
- 1996-04-02 TR TR97/01105T patent/TR199701105T1/xx unknown
- 1996-04-02 EA EA199700209A patent/EA199700209A1/ru unknown
- 1996-04-02 WO PCT/EP1996/001438 patent/WO1996031509A1/en not_active Application Discontinuation
- 1996-04-02 SK SK1332-97A patent/SK133297A3/sk unknown
- 1996-04-02 CA CA002216809A patent/CA2216809A1/en not_active Abandoned
- 1996-04-02 CZ CZ973133A patent/CZ313397A3/cs unknown
- 1996-04-02 CN CN96194403A patent/CN1186492A/zh active Pending
- 1996-04-02 NZ NZ304886A patent/NZ304886A/en unknown
- 1996-04-02 HU HU9801602A patent/HUP9801602A3/hu unknown
-
1997
- 1997-09-25 IS IS4570A patent/IS4570A/is unknown
- 1997-09-30 BG BG101934A patent/BG101934A/xx unknown
- 1997-10-03 NO NO974595A patent/NO974595L/no unknown
Also Published As
Publication number | Publication date |
---|---|
IS4570A (is) | 1997-09-25 |
WO1996031509A1 (en) | 1996-10-10 |
HUP9801602A3 (en) | 1999-01-28 |
BG101934A (en) | 1999-04-30 |
NO974595D0 (no) | 1997-10-03 |
JPH11501049A (ja) | 1999-01-26 |
EA199700209A1 (ru) | 1998-04-30 |
NO974595L (no) | 1997-12-03 |
CN1186492A (zh) | 1998-07-01 |
CZ313397A3 (cs) | 1998-03-18 |
SK133297A3 (en) | 1998-07-08 |
NZ304886A (en) | 1998-11-25 |
MX9707379A (es) | 1997-11-29 |
PL322623A1 (en) | 1998-02-02 |
AU5276696A (en) | 1996-10-23 |
EP0819127A1 (en) | 1998-01-21 |
HUP9801602A2 (hu) | 1998-11-30 |
KR19980703559A (ko) | 1998-11-05 |
TR199701105T1 (xx) | 1998-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2216809A1 (en) | Imidazo[1,2-a]pyridine derivatives | |
US6498166B1 (en) | Pyrazolopyridines | |
US6831097B2 (en) | 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors | |
US7223772B1 (en) | Pyrazolopyridine derivatives as selective cox-2 inhibitors | |
ES2326326T3 (es) | Compuestos y procedimientos para tratar la dislipidemia. | |
RU2696275C1 (ru) | Производные имидазопиридина в качестве модуляторов активности tnf | |
WO2007032466A1 (ja) | 複素環化合物、その製造方法並びに用途 | |
JP6811233B2 (ja) | Tnfアルファの修飾因子として有用な環状化合物 | |
RU2683940C1 (ru) | Производные имидазотиазола в качестве модуляторов активности tnf | |
WO2001038311A2 (en) | Pyrimidine derivatives as selective inhibitors of cox-2 | |
RU2697090C1 (ru) | Производные тетрагидроимидазопиридина в качестве модуляторов активности tnf | |
EP0173520A2 (en) | Tricyclic oxindole antiinflammatory agents | |
MXPA97007379A (en) | Derivatives of imidazo [1,2-a] pirid | |
HRP960425A2 (en) | Chemical compounds | |
JP3167700B1 (ja) | 2,3−ジアリール−ピラゾロ[1,5−b]ピリダジン誘導体、その製造方法およびそのシクロオキシゲナーゼ2(cox−2)阻害剤としての使用 | |
MXPA00002203A (en) | 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors | |
ZA200103344B (en) | Pyrazolopyridine derivatives as selective COX-2 inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |